deltatrials
Completed NCT01734434

Study to Identify Factors Influencing Access of Pregnant Women and Their Infants to Local Healthcare Systems

A Multicenter, Observational Study to Identify Factors That Influence Access of Pregnant Women and Their Infants to Their Local Healthcare Systems

Sponsor: GlaxoSmithKline

Conditions Pregnancy, Newborn Health
Updated 7 times since 2017 Last updated: May 17, 2018 Started: Nov 30, 2012 Primary completion: Jan 31, 2015 Completion: Jan 31, 2015

Listed as NCT01734434, this observational or N/A phase trial focuses on Pregnancy, Newborn Health and remains completed. Sponsored by GlaxoSmithKline, it has been updated 7 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Jan 2019 — Jan 2021 [monthly]

    Completed

  5. Jun 2018 — Jan 2019 [monthly]

    Completed

▶ Show 2 earlier versions

  1. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NA → None

  2. Jan 2017 — Apr 2018 [monthly]

    Completed NA

    First recorded

Nov 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • GlaxoSmithKline
  • Novartis Vaccines
Data source: Novartis

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Cape Town, South Africa
  • • Gauteng, South Africa
  • • Manhiça, Mozambique
  • • Panama City, Panama
  • • Santo Domingo, Dominican Republic
  • • Soweto, Johannesburg, South Africa